Show simple item record

dc.contributor.authorBannister, Margaret*
dc.contributor.authorBerlanga, J.*
dc.date.accessioned2018-02-13T11:30:14Z
dc.date.available2018-02-13T11:30:14Z
dc.date.issued2016-09
dc.identifier.citationBannister M and Berlanga J (2016) Effective utilization of oral hypoglycemic agents to achieve individualized HbA1c targets in patients with type 2 diabetes mellitus. Diabetes Therapy. 7(3): 387-399.
dc.identifier.urihttp://hdl.handle.net/10454/14921
dc.descriptionYes
dc.description.abstractType 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized treatment pathways, including personalized HbA1c targets, this article will explore the mode of action of currently available oral treatments, factors to consider when individualizing HbA1c targets, the relevance of estimated glomerular filtration rate assessment, and the importance of reviewing the clinical impact of all treatment decisions.
dc.language.isoenen
dc.rights© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
dc.subjectHbA1c targets
dc.subjectOral hypoglycemic agents
dc.subjectType 2 diabetes
dc.titleEffective utilization of oral hypoglycemic agents to achieve individualized HbA1c targets in patients with type 2 diabetes mellitus
dc.status.refereedYes
dc.date.Accepted2016
dc.date.application2016-08-08
dc.typeArticle
dc.type.versionPublished version
dc.identifier.doihttps://doi.org/10.1007/s13300-016-0188-5
refterms.dateFOA2018-07-28T03:07:53Z


Item file(s)

Thumbnail
Name:
Bannister_Diabetes_Therapy.pdf
Size:
621.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record